Nonsynonimous mutation of catechol-O-methyl-transferase (COMT) gene in a patient with temporomandibular disorder.

Vincenzo D'Antò, Ambrosina Michelotti, Luciana Esposito, Adriana Zagari, Rosario Liguori, Lucia Sacchetti

Research output: Contribution to journalArticle

Abstract

We report a case of temporomandibular disorder patient with disc displacement without reduction, myofascial pain, limited opening and a novel, never described, nonsynonimous mutation of catechol-O-methyl-transferase (COMT) gene. COMT is one of the enzymes that metabolizes catecholamines, thereby acting as a key modulator of dopaminergic and adrenergic/noradrenergic neurotransmissions, which play a key role in pain modulation. This novel mutation, p.R58S, changed a codon (58 from arginine to serine) in the COMT protein. The introduction of a serine residue in a highly organised secondary structure, in critical regions of the protein, results in a structural alteration. Therefore, we speculate an influence of the mutation on the high pain sensitivity of the patient.

Original languageEnglish
Pages (from-to)174-179
Number of pages6
JournalProgress in Orthodontics
Volume11
Issue number2
Publication statusPublished - 2010

ASJC Scopus subject areas

  • Orthodontics

Fingerprint Dive into the research topics of 'Nonsynonimous mutation of catechol-O-methyl-transferase (COMT) gene in a patient with temporomandibular disorder.'. Together they form a unique fingerprint.

  • Cite this

    D'Antò, V., Michelotti, A., Esposito, L., Zagari, A., Liguori, R., & Sacchetti, L. (2010). Nonsynonimous mutation of catechol-O-methyl-transferase (COMT) gene in a patient with temporomandibular disorder. Progress in Orthodontics, 11(2), 174-179.